Tumors are a major cause of death worldwide, and much effort has been made to develop appropriate anti-tumor therapies. Existing in vitro and in vivo tumor models cannot reflect the critical features of cancer. The development of organ-on-a-chip models has enabled the integration of organoids, microfluidics, tissue engineering, biomaterials research, and microfabrication, offering conditions that mimic tumor physiology. Three-dimensional in vitro human tumor models that have been established as organ-on-a-chip models contain multiple cell types and a structure that is similar to the primary tumor. These models can be applied to various foci of oncology research. Moreover, the high-throughput features of microfluidic organ-on-a-chip models offer new opportunities for achieving large-scale drug screening and developing more personalized treatments. In this review of the literature, we explore the development of organ-on-a-chip technology and discuss its use as an innovative tool in basic and clinical applications and summarize its advancement of cancer research. Graphical abstract: [Figure not available: see fulltext.]
CITATION STYLE
Yu, Y., Zhou, T. T., & Cao, L. (2023, December 1). Use and application of organ-on-a-chip platforms in cancer research. Journal of Cell Communication and Signaling. Springer Science and Business Media B.V. https://doi.org/10.1007/s12079-023-00790-7
Mendeley helps you to discover research relevant for your work.